Novel Liver-Targeting Drug Offers Hope for AAT Deficiency

The investigational drug fazirsiran improved important liver parameters associated with alpha-1-antitrypsin deficiency.
Medscape Medical News

source https://www.medscape.com/viewarticle/976287?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?